Neutrophil gelatinase-associated lipid carrier protein (NGAL), which is abundantly expressed and substantially upregulated in the kidney, is thought to be a novel biomarker with a high sensitivity for the detection of AKI (Shang and Wang, 2017). This evidence concerns the gene LCN2 and acute kidney injury.